March 1, 2013
Zyngenia Inc. publishes new data demonstrating preclinical efficacy of its multi-specific antibody therapeutics in treating cancer.
View Press Release
October 11, 2012
Zyngenia Inc. expands its board of directors with leading life sciences business executives Christian Itin and Jason Rhodes.
View Press Release
April 25, 2012
Zyngenia Inc. recruits David Parkinson, M.D., as board member, clinical advisory board head, and interim chief medical officer.
View Press Release
December 12, 2011
Zyngenia Inc. promotes chief scientific officer and hires chief business officer.
May 19, 2011
Tech Council of Maryland names Zyngenia, Inc. as 2011 Emerging Company of the Year.
September 08, 2010
Zyngenia Inc. raises $15 million in series of extension financing.
March 11, 2010
County, state announce milestone investments in biotherapeutics company Zyngenia Inc.
November 4, 2009
Zyngenia Inc. secures $10 million in Series A funding.
